APA (7th ed.) Citation

U, A., ZA, N., OU, R., MA, R., A, N., K, A. R., . . . M, S. (2026). Efficacy and Safety of Camrelizumab Combination Therapy in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. American journal of clinical oncology. https://doi.org/10.1097/COC.0000000000001299

Chicago Style (17th ed.) Citation

U, Akram, et al. "Efficacy and Safety of Camrelizumab Combination Therapy in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis." American Journal of Clinical Oncology 2026. https://doi.org/10.1097/COC.0000000000001299.

MLA (9th ed.) Citation

U, Akram, et al. "Efficacy and Safety of Camrelizumab Combination Therapy in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis." American Journal of Clinical Oncology, 2026, https://doi.org/10.1097/COC.0000000000001299.